Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimising drug utilisation in long term care.

Kate L Lapane1, Carmel M Hughes

  • 1Department of Community Health, Brown Medical School, Brown University, Providence, Rhode Island 02912, USA. Kate_Lapane@brown.edu

Pharmacoeconomics
|April 4, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the current status of pharmacist prescribing in Middle Eastern Arab countries: a scoping review.

International journal of clinical pharmacy·2026
Same author

Assessing Older Adults' Adherence to Appropriate Polypharmacy: Selection of Outcome Measures for Intervention Trials.

Journal of the American Geriatrics Society·2026
Same author

Antidepressant and anxiolytic medications and risk of mortality in people with dementia: A nested case-control study in Northern Ireland.

Journal of Alzheimer's disease : JAD·2026
Same author

Monitoring antimicrobial resistance in care homes through wastewater surveillance: a scoping review.

The Journal of hospital infection·2025
Same author

Perspectives of patients on the role of general practice pharmacists: a systematic review and meta-synthesis of qualitative studies.

BMC primary care·2025
Same author

Barriers and Facilitators to Medicines Use in Patients With Vision Impairment: A Theory-Informed Qualitative Study of Patients and Caregivers.

Health expectations : an international journal of public participation in health care and health policy·2025
Same journal

Use and Outcomes of Cost-Effectiveness Analyses and Additional Considerations in Pharmaceutical Reimbursement in the Netherlands.

PharmacoEconomics·2026
Same journal

SMART Planning of Early-Stage Health Economic Decision Models for Mechanism-Based Precision Treatments in Rare Cancers: An Application and Tool Update.

PharmacoEconomics·2026
Same journal

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

PharmacoEconomics·2026
Same journal

Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

PharmacoEconomics·2026
Same journal

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same journal

A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

PharmacoEconomics·2026
See all related articles

Suboptimal pharmacotherapy is common in elderly patients, posing challenges for long-term care. Addressing this requires multifaceted strategies, including regulatory and non-regulatory approaches, to improve prescribing quality and patient outcomes.

Area of Science:

  • Gerontology
  • Pharmacology
  • Health Policy

Background:

  • Quality long-term care for the elderly faces cost containment challenges.
  • Suboptimal pharmacotherapy is a prevalent issue among the elderly, varying internationally.
  • Improving and rationalizing medication use in older adults requires a creative, multifaceted approach.

Purpose of the Study:

  • To outline non-regulatory and regulatory strategies for improving pharmacotherapy in the elderly.
  • To examine US regulatory approaches to enhance prescribing within long-term care settings.
  • To evaluate a quality indicator for stimulating appropriate prescribing in coronary heart disease.

Main Methods:

  • Review of non-regulatory and regulatory efforts in improving elderly pharmacotherapy.

Related Experiment Videos

  • Analysis of US prospective payment systems and their impact on medication costs.
  • Assessment of a specific quality indicator for coronary heart disease prescribing.

    • Main Results:

    • Regulatory approaches, such as those considered by US bodies, can improve prescribing.
    • Quality indicators can stimulate better prescribing practices, exemplified by coronary heart disease care.
    • A prospective payment system in the US highlights the need for regulatory oversight to balance cost containment and medication quality.

    Conclusions:

    • Regulatory measures can enhance prescribing, but a holistic, patient-centered approach with multidisciplinary teams is the ultimate goal.
    • Appropriate drug therapy significantly impacts outcomes for the elderly.
    • A cultural shift in societal views and treatment of the elderly is necessary for substantial improvements in long-term care.